Home
/
Xtant Medical Holdings, Inc.
/
Financials
/
Quarterly
Xtant Medical Holdings, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Xtant Medical Holdings, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2020
Sep 30, 2020
$14.02M
Oct 29, 2020
Q2
2020
Jun 30, 2020
$10.53M
Aug 3, 2020
Q1
2020
Mar 31, 2020
$14.78M
May 7, 2020
Q3
2020
Sep 30, 2019
$15.72M
Oct 29, 2020
Q2
2020
Jun 30, 2019
$15.27M
Aug 3, 2020
Q1
2020
Mar 31, 2019
$16.73M
May 7, 2020
Q3
2019
Sep 30, 2018
$17.27M
Nov 7, 2019
Q2
2019
Jun 30, 2018
$18.74M
Aug 8, 2019
Q1
2019
Mar 31, 2018
$17.93M
May 15, 2019
Q3
2018
Sep 30, 2017
$19.79M
Nov 14, 2018
Q2
2018
Jun 30, 2017
$21.41M
Aug 8, 2018
Q3
2013
Sep 30, 2013
$10.50M
Nov 14, 2013
Q1
2012
Mar 31, 2012
$7.77M
May 4, 2012
Q3
2011
Sep 30, 2011
$7.54M
Nov 14, 2011
Q2
2011
Jun 30, 2011
$7.51M
Aug 15, 2011
Q1
2012
Mar 31, 2011
$6.00M
May 4, 2012
Q3
2011
Sep 30, 2010
$4.19M
Nov 14, 2011
Q2
2011
Jun 30, 2010
$3.20M
Aug 15, 2011
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$33.26M
Nov 10, 2025
Q2
2025
Jun 30, 2025
$35.41M
Aug 12, 2025
Q1
2025
Mar 31, 2025
$32.90M
May 12, 2025
Q3
2025
Sep 30, 2024
$27.94M
Nov 10, 2025
Q2
2025
Jun 30, 2024
$29.94M
Aug 12, 2025
Q1
2025
Mar 31, 2024
$27.87M
May 12, 2025
Q3
2024
Sep 30, 2023
$25.02M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$20.23M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$17.94M
May 15, 2024
Q3
2023
Sep 30, 2022
$14.46M
Nov 14, 2023
Q2
2023
Jun 30, 2022
$15.28M
Aug 1, 2023
Q1
2023
Mar 31, 2022
$12.96M
May 4, 2023
Q3
2022
Sep 30, 2021
$13.78M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$14.98M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$12.54M
May 5, 2022
Q3
2021
Sep 30, 2020
$14.02M
Nov 12, 2021
Q2
2021
Jun 30, 2020
$10.53M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$14.78M
May 11, 2021
Q3
2020
Sep 30, 2019
$15.72M
Oct 29, 2020
Q2
2020
Jun 30, 2019
$15.27M
Aug 3, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$17.93M
May 8, 2018
Q3
2017
Sep 30, 2017
$19.79M
Nov 21, 2017
Q2
2017
Jun 30, 2017
$21.41M
Mar 30, 2018
Q1
2018
Mar 31, 2017
$22.08M
May 8, 2018
Q3
2017
Sep 30, 2016
$23.09M
Nov 21, 2017
Q2
2017
Jun 30, 2016
$21.46M
Mar 30, 2018
Q1
2017
Mar 31, 2016
$20.98M
Mar 30, 2018
Q3
2016
Sep 30, 2015
$17.69M
Nov 10, 2016
Q2
2016
Jun 30, 2015
$9.89M
Aug 10, 2016
Q1
2016
Mar 31, 2015
$9.50M
May 11, 2016
Q3
2015
Sep 30, 2014
$8.45M
Nov 16, 2015
Q2
2015
Jun 30, 2014
$8.88M
Aug 14, 2015
Q1
2015
Mar 31, 2014
$8.91M
May 6, 2015
Q3
2014
Sep 30, 2013
$7.93M
Nov 7, 2014
Q2
2014
Jun 30, 2013
$8.27M
Aug 14, 2014
Q1
2014
Mar 31, 2013
$8.62M
May 12, 2014
Q3
2013
Sep 30, 2012
$8.88M
Nov 14, 2013
Q2
2013
Jun 30, 2012
$8.21M
Aug 13, 2013
Q1
2013
Mar 31, 2012
$7.77M
May 10, 2013
Q3
2012
Sep 30, 2011
$7.54M
Nov 8, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.31M
Nov 10, 2025
Q2
2025
Jun 30, 2025
$3.55M
Aug 12, 2025
Q3
2025
Jun 30, 2025
$3.55M
Nov 10, 2025
Q3
2025
Mar 31, 2025
$58.0K
Nov 10, 2025
Q1
2025
Mar 31, 2025
$58.0K
May 12, 2025
Q2
2025
Mar 31, 2025
$58.0K
Aug 12, 2025
Q3
2025
Sep 30, 2024
($5.02M)
Nov 10, 2025
Q3
2025
Jun 30, 2024
($3.86M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($3.86M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($4.40M)
May 12, 2025
Q3
2025
Mar 31, 2024
($4.40M)
Nov 10, 2025
Q2
2025
Mar 31, 2024
($4.40M)
Aug 12, 2025
Q3
2024
Sep 30, 2023
$9.23M
Nov 12, 2024
Q3
2024
Jun 30, 2023
($2.19M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($2.19M)
Aug 8, 2024
Q3
2024
Mar 31, 2023
($2.08M)
Nov 12, 2024
Q2
2024
Mar 31, 2023
($2.08M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($2.08M)
May 15, 2024
Q3
2023
Sep 30, 2022
($2.35M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($1.71M)
Aug 1, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.54M
Nov 10, 2025
Q2
2025
Jun 30, 2025
$4.62M
Aug 12, 2025
Q1
2025
Mar 31, 2025
$1.06M
May 12, 2025
Q3
2025
Sep 30, 2024
($3.78M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($2.95M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($3.47M)
May 12, 2025
Q3
2024
Sep 30, 2023
($3.39M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($1.39M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($1.58M)
May 15, 2024
Q3
2023
Sep 30, 2022
($1.90M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($1.30M)
Aug 1, 2023
Q1
2023
Mar 31, 2022
($1.83M)
May 4, 2023
Q3
2022
Sep 30, 2021
($1.45M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($491.0K)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($5.0K)
May 5, 2022
Q3
2021
Sep 30, 2020
$760.0K
Nov 12, 2021
Q2
2021
Jun 30, 2020
($387.0K)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($1.36M)
May 11, 2021
Q3
2020
Sep 30, 2019
($705.0K)
Oct 29, 2020
Q2
2020
Jun 30, 2019
($563.0K)
Aug 3, 2020